Biotrakson en es it fr

Biotrakson Brand names, Biotrakson Analogs

Biotrakson Brand Names Mixture

  • No information avaliable

Biotrakson Chemical_Formula


Biotrakson RX_link

Biotrakson fda sheet

Biotrakson FDA

Biotrakson msds (material safety sheet)

Biotrakson MSDS

Biotrakson Synthesis Reference

M. Montavon, R. Reiner, Brit. pat. Appl. 2,022,090; eidem, U.S. pat. 4,327,210 (1979, 1982 both to Hoffmann-La Roche)

Biotrakson Molecular Weight

554.583 g/mol

Biotrakson Melting Point

>155 oC

Biotrakson H2O Solubility

No information avaliable

Biotrakson State


Biotrakson LogP


Biotrakson Dosage Forms

IM infusion;

Biotrakson Indication

For the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph

Biotrakson Pharmacology

Ceftriaxone is a cephalosporin/cephamycin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. Ceftriaxone has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Ceftriaxone results from the inhibition of cell wall synthesis and is mediated through Ceftriaxone binding to penicillin binding proteins (PBPs). Ceftriaxone is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.

Biotrakson Absorption

No information avaliable

Biotrakson side effects and Toxicity

No information avaliable

Biotrakson Patient Information

Patient Information:

Patients should be counseled that antibacterial drugs including Ceftriaxone should only be used to
treat bacterial infections. They do not treat viral infections (eg, common cold). When Ceftriaxone
is prescribed to treat a bacterial infection, patients should be told that although it is common
to feel better early in the course of therapy, the medication should be taken exactly as directed.
Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of
the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and
will not be treatable by Ceftriaxone or other antibacterial drugs in the future.

Biotrakson Organisms Affected

Enteric bacteria and other eubacteria